India, Sept. 17 -- In 1887, the British historian Lord Acton wrote that "power tends to corrupt, and absolute power corrupts absolutely". For decades, an experiment held at Stanford University in 1971... Read More
India, Sept. 14 -- Chinese President Xi Jinping on Sunday proposed a Brics open-source artificial intelligence community, offering the grouping a Beijing-led alternative to the closed-model ecosystems... Read More
India, Sept. 11 -- Scientists working inside state-supported research programmes have used Anthropic's Claude models to help plan and write up experiments that could feed into biological weapons devel... Read More
India, Sept. 10 -- Anthropic researcher Jacob Coxon resigned on Wednesday and wrote on X that AI companies were "racing straight to self-improving superintelligence and gambling with our lives". An ex... Read More
India, Sept. 8 -- A Boeing 767 freighter carrying Amazon cargo touched down on runway 30 at Miami International Airport at about 1.58pm local time on Sunday, ran out of pavement, went through the peri... Read More
India, Sept. 3 -- In a report published on August 28, Binod Parajuli set out what the satellite pictures showed about the origins of the August 26 tragedy. A senior divisional hydrologist in the flood... Read More
India, Aug. 27 -- The US has approved the first drug to hit the molecular cause of most pancreatic cancers, a once-daily pill that in its pivotal trial extended survival to 13.2 months from 6.7 months... Read More
India, Aug. 27 -- The US has approved the first drug to hit the molecular cause of most pancreatic cancers, a once-daily pill that in its pivotal trial extended survival to 13.2 months from 6.7 months... Read More
India, Aug. 20 -- Merck and Moderna announced on Wednesday morning that a bespoke mRNA cancer vaccine, given alongside Merck's blockbuster immunotherapy Keytruda after surgery, significantly reduced d... Read More
New Delhi, Aug. 20 -- Merck and Moderna announced on Wednesday morning that a bespoke mRNA cancer vaccine, given alongside Merck's blockbuster immunotherapy Keytruda after surgery, significantly reduc... Read More